High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge

Author:

Ujjainiya Rajat,Tyagi Akansha,Sardana Viren,Naushin Salwa,Bhatheja Nitin,Kumar Kartik,Barman Joydeb,Prakash Satyartha,Kutum RintuORCID,Bhaskar Akash Kumar,Singh Prateek,Chaudhary Kumardeep,Loomba Menka,Khanna Yukti,Walecha Chestha,Ahmed Rizwan,Yadav Ashutosh,Bajaj Archana,Malik Gaurav,Qureshi Sahar,Waghdhare Swati,Siddiqui Samreen,Trehan Kamal Krishan,Mani Manju,Dang Rajiv,Das Poonam,Dougall Pankaj,Mahajan Monica,Sonar Sudipta,Jakhar Kamini,Kumar Reema,Tiwari MahimaORCID,Mani ShailendraORCID,Bhattacharyya Sankar,Budhiraja Sandeep,Agrawal Anurag,Dash DebasisORCID,Jha SujeetORCID,Sengupta ShantanuORCID

Abstract

AbstractImmunization is expected to confer protection against infection and severe disease for vaccines while reducing risks to unimmunized populations by inhibiting transmission. Here, based on serial serological studies of an observational cohort of healthcare workers, we show that during a Severe Acute Respiratory Syndrome -Coronavirus 2 Delta-variant outbreak in Delhi, 25.3% (95% Confidence Interval 16.9-35.2) of previously uninfected, ChAdOx1-nCoV19 double vaccinated, healthcare workers were infected within less than two months, based on serology. Induction of anti-spike response was similar between groups with breakthrough infection (541 U/ml, Inter Quartile Range 374) and without (342 U/ml, Inter Quartile Range 497), as was the induction of neutralization activity to wildtype. This was not vaccine failure since vaccine effectiveness estimate based on infection rates in an unvaccinated cohort were about 70% and most infections were asymptomatic. We find that while ChAdOx1-nCoV19 vaccination remains effective in preventing severe infections, it is unlikely to be completely able to block transmission and provide herd immunity.

Funder

Council of Scientific and Industrial Research

Council of Scientific and Industrial Research (CSIR) MLP 2007

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3